Radiopharm Theranostics Health Care
Biotech Cancer Healthcare Medical

$0.105 -0.010 (-8.70%)

High $0.12	Low $0.10	Trades 57	Turnover $206,557	Volume 1,951,148
30 June 2023 at 4:10pm

Please note that we source our information from many sources. The below may not be accurate, or up to date. Please bear with us whilst we fine tune our data collection. In the meantime, we do not recommend relying on the below. It is merely a guide!

Stock Information

Code RAD	Name Radiopharm Theranostics Ltd	Country AU	Currency AUD
GIC Sector Health Care	GIC Group Pharmaceuticals, Biotechnology & Life Sciences	GIC Industry Biotechnology	GIC Sub Industry Biotechnology
Sector Healthcare	IPO Date N/A	Fiscal Year June	Type Common Stock
Shares Outstanding 2,364,949,502	Shares Floated 2,487,472,670	Held by Insiders 28.093%	Held by Institutions 11.852%

Directors & Officers

Name & Education	Position
Mr. Paul Edward-Alexander Hopper A.S.i.A, B.A (UNSW), FAICD	Founder & Executive Chairman
Mr. Riccardo Canevari	MD, CEO & Director
Dr. Dimitris Voliotis M.D.	Chief Medical Officer
Mr. Aaron Laurita	Chief Financial Officer
Mr. Hitesh Goel	Head of Project Management
Mr. Nathan Jong C.A.	Joint Company Secretary
Ms. Amritha Sushil	Joint Company Secretary

RAD Historic Dividends

Date	Amount
We found no dividends on record for RAD.

End of Day Prices

Date	Close	Volume	Change
23-Jul	$0.02	0	0.00 (0.00%)
22-Jul	$0.02	0	0.00 (0.00%)
21-Jul	$0.02	205,220	0.00 (5.00%)
20-Jul	$0.02	4,316,363	0.00 (0.00%)
17-Jul	$0.02	74,719	-0.01 (41.18%)
18-Sep	$0.03	7,214,173	+0.00 (9.68%)
12-Sep	$0.03	19,871,583	+0.00 (6.90%)
11-Sep	$0.03	6,388,015	+0.00 (3.57%)
05-Sep	$0.03	2,120,535	0.00 (0.00%)
04-Sep	$0.03	4,651,023	+0.00 (5.66%)
03-Sep	$0.03	599,603	0.00 (5.36%)
29-Aug	$0.03	977,963	+0.00 (1.82%)
28-Aug	$0.03	1,712,009	+0.00 (1.85%)
22-Aug	$0.03	3,476,593	0.00 (10.00%)
21-Aug	$0.03	46,600,598	+0.00 (15.38%)
7 up, 4 down, and 4 flat days

Market Cap (23-Jul) $44,934,040	EBITDA -	PE 0.00	Book Value $0.02
Dividend per Share N/A	Dividend Yield N/A	EPS $-0.02	Profit Margin N/A
Operating Margin -423.75%	ROA 28.33%	ROE 92.1%	Revenue (FY) $16,278,428
Revenue per Share $0.01	Gross Profit (FY) $-22,221,420	Q' YOY Revenue Growth 154.5%	Q' YOY Earnings Growth -

Radiopharm Theranostics Health Care
Biotech Cancer Healthcare Medical

Stock Information

Technicals

Financial Snapshot (December 2025)

Directors & Officers

RAD Historic Dividends

Followers

Prices

Announcements

End of Day Prices

RAD Radiopharm Theranostics Health Care Biotech Cancer Healthcare Medical

Stock Information

Technicals

Financial Snapshot (December 2025)

Directors & Officers

RAD Historic Dividends

Followers

Prices

Announcements

End of Day Prices

Radiopharm Theranostics Health Care
Biotech Cancer Healthcare Medical